| Website | genticel.com |
| Category | BioTech |
| Employees | |
| Description | Cervical Cancer BioPharma Company |
| TOTAL | $17.7M |
| VENTURE FUNDING TOTAL | $17.7M |
| Series C, 4/10 IDInvest Partners Amundi Private Equity Funds InnoBio Fund Edmond de Rothschild Venture Capital | $17.7M |
Gentiel is a clinical-stage biopharmaceutical company focused on therapeutic vaccines for the prevention of cervical cancer in HPV infected women.